COMPETITIVENESS OPERATIONAL PROGRAMME 2014-2020
PRIORITY AXIS 1 – RESEARCH, TECHNOLOGICAL DEVELOPMENT AND INNOVATION (RD&I) TO SUPPORT ECONOMIC COMPETITIVENESS AND BUSINESS DEVELOPMENT
ACTION 1.1.4 Attracting high-level personnel from abroad in order to enhance the RD capacity
Molecular Profiling of Myeloproliferative Neoplasms and Acute Myeloid Leukemia for Designing Early Diagnostic, Prognostic and Treatment Strategies (MYELOAL – EDIAPROT)
Project co-funded by the European Regional Development Fund through the COMPETITIVENESS 2014-2020 Operational Program.
For detailed information about other programs co-funded by the European Union, please visit www.fonduri-ue.ro.
“The content of this material does not necessarily represent the official position of the European Union or the Government of Romania”
February 2017
The Stefan S. Nicolau Institute of Virology, located at 285 Mihai Bravu Road, Sector 3, Bucharest, is implementing the project “Molecular Profiling of Myeloproliferative Neoplasms and Acute Myeloid Leukemia for Designing Early Diagnostic, Prognostic and Treatment Strategies (MYELOAL-EDIAPROT)” starting from 26.10.2016, co-financed by the European Regional Development Fund, under the financing grant agreement with the National Authority for Scientific Research and Innovation as Intermediate Body, on behalf and for the Ministry of European Funds as Managing Authority for the Operational Program Competitiveness 2014-2020.
The total value of the project is: 8,672,500 lei
of which the non-reimbursable financial assistance is 8,617,500 lei
The eligible non-reimbursable value from ERDF: 7,276,617 lei (84.44%)
The eligible non-reimbursable value from the national budget: 1,340,883 lei (15.56%)
The project is implemented in Bucharest for a period of 48 months.
The objective of the project is to establish a high-level nucleus of competence in studying molecular mechanisms of Myeloproliferative Neoplasms (MPNs), their transformation into Secondary Acute Myeloid Leukemia (sAML), and de novo AML with normal karyotype (dnAML), in a medical institute from Romanian Academy, under the leadership of a researcher with trail-blazing discoveries in the field, and remarkable international experience in the private research sector (Ludwig Institute of Cancer Research, Ltd.), as well as in academic research (Fonds National de la Recherche Scientifique Belgium (FNRS) and Université Catholique de Louvain).
Contact information:
Dr. Carmen C. Diaconu
Position: Executive Coordinator
“Stefan S. Nicolau” Institute of Virology
285 Mihai Bravu Road, Sector 3, Bucharest,
Tel: 0213242590; Fax: 0213242590
e-mail: ccdiaconu@yahoo.com; carmen.diaconu@virology.ro
